Drugmaker Lilly said its experimental pill, orforglipron, produced better blood sugar and weight loss for diabetes patients results in a new head-to-head clinical trial.

Feb 26 (Reuters) - Eli Lilly's experimental weight-loss pill, orforglipron, caused more side effects and treatment ...

Orforglipron carried more side effects, however ...

Experts have hailed a powerful new weapon in the fight against Type 2 diabetes – a simple daily pill that can help people shed pounds and bring their blood sugar levels under control. Orfroglipron, ...

A major new clinical trial involving more than 1,600 people has found that a GLP-1 pill form of the drug orforglipron works about as well as injectable semaglutide for people with type 2 diabetes.

Eli Lilly released new data on its oral pill, orforglipron, Thursday, showing it's almost as good as Ozempic. The pill may be available this spring.

Women with type 2 diabetes who started on metformin rather than a sulfonylurea had roughly 30 percent lower odds of dying before age 90, according to a new study built on decades of data from the ...

Abbott has entered into a commercialisation agreement with Novo Nordisk India to market a second brand of semaglutide, ...

A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 ...

Abbott partners with Novo Nordisk to launch Extensior, a second Ozempic brand for type 2 diabetes management in India.

Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage—not by controlling blood sugar as originally ...

Lifestyle Changes for Diabetes: Diabetes affects a large population worldwide. India also has a significant number of patients. Let us explain whether it is possible to stop taking medication. Do I ...